http://bio2rdf.org/drugbank_resource:DB00714_DB01624_nanopub.RAvKA8NzYQHXxcDQS1f_2CckNiMQl5NpnFi65om4wu6CA#head http://bio2rdf.org/drugbank_resource:DB00714_DB01624_nanopub.RAvKA8NzYQHXxcDQS1f_2CckNiMQl5NpnFi65om4wu6CA http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00714_DB01624_nanopub.RAvKA8NzYQHXxcDQS1f_2CckNiMQl5NpnFi65om4wu6CA#assertion http://bio2rdf.org/drugbank_resource:DB00714_DB01624_nanopub.RAvKA8NzYQHXxcDQS1f_2CckNiMQl5NpnFi65om4wu6CA http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00714_DB01624_nanopub.RAvKA8NzYQHXxcDQS1f_2CckNiMQl5NpnFi65om4wu6CA#provenance http://bio2rdf.org/drugbank_resource:DB00714_DB01624_nanopub.RAvKA8NzYQHXxcDQS1f_2CckNiMQl5NpnFi65om4wu6CA http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00714_DB01624_nanopub.RAvKA8NzYQHXxcDQS1f_2CckNiMQl5NpnFi65om4wu6CA#publicationInfo http://bio2rdf.org/drugbank_resource:DB00714_DB01624_nanopub.RAvKA8NzYQHXxcDQS1f_2CckNiMQl5NpnFi65om4wu6CA http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00714_DB01624_nanopub.RAvKA8NzYQHXxcDQS1f_2CckNiMQl5NpnFi65om4wu6CA#assertion http://bio2rdf.org/drugbank:DB00714 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00714_DB01624 http://bio2rdf.org/drugbank:DB01624 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00714_DB01624 http://bio2rdf.org/drugbank_resource:DB00714_DB01624 http://purl.org/dc/terms/identifier drugbank_resource:DB00714_DB01624 http://bio2rdf.org/drugbank_resource:DB00714_DB01624 http://purl.org/dc/terms/title DDI between Apomorphine and Zuclopenthixol - Additive QTc prolongation may occur. Consider alternate therapy or use caution and monitor for QTc prolongation as this can lead to Torsade de Pointes (TdP). Antagonism may also occur between zuclopenthixol, a dopamine D2 receptor antagonist, and apomorphine, a dopamine agonist. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of both agents if concurrent therapy is initiated, discontinued or dose(s) changed. http://bio2rdf.org/drugbank_resource:DB00714_DB01624 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00714_DB01624 http://www.w3.org/2000/01/rdf-schema#label DDI between Apomorphine and Zuclopenthixol - Additive QTc prolongation may occur. Consider alternate therapy or use caution and monitor for QTc prolongation as this can lead to Torsade de Pointes (TdP). Antagonism may also occur between zuclopenthixol, a dopamine D2 receptor antagonist, and apomorphine, a dopamine agonist. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of both agents if concurrent therapy is initiated, discontinued or dose(s) changed. [drugbank_resource:DB00714_DB01624] http://bio2rdf.org/drugbank_resource:DB00714_DB01624_nanopub.RAvKA8NzYQHXxcDQS1f_2CckNiMQl5NpnFi65om4wu6CA#provenance http://bio2rdf.org/drugbank_resource:DB00714_DB01624_nanopub.RAvKA8NzYQHXxcDQS1f_2CckNiMQl5NpnFi65om4wu6CA#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00714_DB01624_nanopub.RAvKA8NzYQHXxcDQS1f_2CckNiMQl5NpnFi65om4wu6CA#publicationInfo http://bio2rdf.org/drugbank_resource:DB00714_DB01624_nanopub.RAvKA8NzYQHXxcDQS1f_2CckNiMQl5NpnFi65om4wu6CA#signature.MCwCFFfmM-n0kA4i http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB00714_DB01624_nanopub.RAvKA8NzYQHXxcDQS1f_2CckNiMQl5NpnFi65om4wu6CA#signature.MCwCFFfmM-n0kA4i http://purl.org/nanopub/x/hasSignature MCwCFFfmM+n0kA4iz8HgfOuyNPSe2cdQAhQP/a3wOrSWZXdIZXCBPANRF6uuWg== http://bio2rdf.org/drugbank_resource:DB00714_DB01624_nanopub.RAvKA8NzYQHXxcDQS1f_2CckNiMQl5NpnFi65om4wu6CA#signature.MCwCFFfmM-n0kA4i http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00714_DB01624_nanopub.RAvKA8NzYQHXxcDQS1f_2CckNiMQl5NpnFi65om4wu6CA http://purl.org/dc/terms/created 2018-03-30T11:12:17.918+02:00 http://bio2rdf.org/drugbank_resource:DB00714_DB01624_nanopub.RAvKA8NzYQHXxcDQS1f_2CckNiMQl5NpnFi65om4wu6CA http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00714_DB01624_nanopub.RAvKA8NzYQHXxcDQS1f_2CckNiMQl5NpnFi65om4wu6CA http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00714_DB01624_nanopub.RAvKA8NzYQHXxcDQS1f_2CckNiMQl5NpnFi65om4wu6CA#signature.MCwCFFfmM-n0kA4i http://bio2rdf.org/drugbank_resource:DB00714_DB01624_nanopub.RAvKA8NzYQHXxcDQS1f_2CckNiMQl5NpnFi65om4wu6CA http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234